TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29606711

Group type: EXPERIMENTAL
Intervention: Mental health first aid training (MHFA)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Postnatal depression (PND) roleplay
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Suicide roleplay
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Both roleplays (PND and suicide)
Number of subjects: 163
Study: 28597226

Group type: EXPERIMENTAL
Intervention: AL 441 mg q4wk
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: AL 882 mg q6wk
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: AL 1064 mg q8wk
Number of subjects: 140
Study: 25428945

Group type: EXPERIMENTAL
Intervention: Speckle tracking echocardiography (STE) in CKD patients
Number of subjects: 106
Study: 23952901

Group type: EXPERIMENTAL
Intervention: Auditory presentation of a story through headphones
Number of subjects: 110

Group type: COMPARATOR
Intervention: Routine care with no auditory recording (Control)
Number of subjects: 110
Study: 21145034

Group type: EXPERIMENTAL
Intervention: Oxytocin during first and second stages of labor
Number of subjects: 11323

Group type: EXPERIMENTAL
Intervention: Active management of third stage of labor (AMTSL)
Number of subjects: 11323
Study: 18498885

Group type: EXPERIMENTAL
Intervention: Mineral trioxide aggregate (MTA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Calcium hydroxide (CH)
Number of subjects: 20
Study: 17023435

Group type: EXPERIMENTAL
Intervention: Trabeculectomy with 1000 cGy beta radiation
Number of subjects: 450

Group type: COMPARATOR
Intervention: Standard trabeculectomy without beta radiation (placebo)
Number of subjects: 450
Study: 12687595

Group type: COMPARATOR
Intervention: Systemic dexamethasone and aerosol placebo (Control)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: High-dose aerosol beclomethasone (2.40-3.69 microg/kg/day)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Medium-dose aerosol beclomethasone (1.0-1.85 microg/kg/day)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Low-dose aerosol beclomethasone (0.48-0.74 microg/kg/day)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Systemic dexamethasone (Control)
Number of subjects: 61
Study: 11085838

Group type: EXPERIMENTAL
Intervention: Educational video about colon cancer screening
Number of subjects: 249

Group type: COMPARATOR
Intervention: Generic brochure on automobile safety (Control)
Number of subjects: 249
Study: 8642081

Group type: EXPERIMENTAL
Intervention: 25% glycolic, lactic, or citric acid lotion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo lotion
Number of subjects: 0
Study: 1471614

Group type: EXPERIMENTAL
Intervention: Ninjinyoeito
Number of subjects: 3
Study: 6363490

Group type: EXPERIMENTAL
Intervention: Relaxation technique (deep abdominal breathing, tensing and relaxing body parts, relaxation by autosuggestion, voluntary image control)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Relaxation technique
Number of subjects: 22
Study: 31750484

Group type: EXPERIMENTAL
Intervention: Purple rice
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Yunlu29 (red) rice
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Reiziq (brown) rice
Number of subjects: 22
Study: 28337945

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy integrated with motivational interviewing (MI-CBT)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy alone (CBT)
Number of subjects: 85
Study: 27080115

Group type: EXPERIMENTAL
Intervention: Ibuprofen/Paracetamol
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Diclofenac K/Paracetamol
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Mefenamic Acid/Paracetamol
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Paracetamol alone
Number of subjects: 170

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 170
Study: 24535029

Group type: EXPERIMENTAL
Intervention: Corticosteroid withdrawal (CSW)
Number of subjects: 872

Group type: COMPARATOR
Intervention: Corticosteroid continuation (CSC)
Number of subjects: 872
Study: 22775123

Group type: EXPERIMENTAL
Intervention: Anxious participants
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nonanxious participants
Number of subjects: 40
Study: 20434544

Group type: EXPERIMENTAL
Intervention: Two-dose regimen of combined hepatitis A and B vaccine (0, 6 months, Adult formulation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three-dose regimen of combined hepatitis A and B vaccine (0, 1, 6 months, Paediatric formulation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Challenge dose of hepatitis B vaccine administered to subjects with anti-HBs antibody concentration < or =10mIU/mL
Number of subjects: 0
Study: 18300356

Group type: EXPERIMENTAL
Intervention: Sequential therapy with lamivudine-IFN-alpha 2b for 48 weeks
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Lamivudine monotherapy for 48 weeks
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: IFN-alpha 2b monotherapy for 24 weeks
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Patients with HBeAg seroconversion
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Patients with sustained virological response after 24 weeks of therapy withdrawal
Number of subjects: 71

Group type: COMPARATOR
Intervention: HBV genotype C
Number of subjects: 71
Study: 16231260

Group type: EXPERIMENTAL
Intervention: Continuous fluconazole (200 mg 3 times weekly)
Number of subjects: 829

Group type: COMPARATOR
Intervention: Episodic fluconazole (provided only for episodes of OPC or EC)
Number of subjects: 829

Group type: EXPERIMENTAL
Intervention: Continuous fluconazole
Number of subjects: 829

Group type: COMPARATOR
Intervention: Episodic fluconazole
Number of subjects: 829
Study: 11249886

Group type: EXPERIMENTAL
Intervention: Aggressive strategy (maximum burr/artery >0.70 with adjunctive balloon inflation < or = 1 atm)
Number of subjects: 497

Group type: COMPARATOR
Intervention: Routine strategy (maximum burr/artery < or = 0.70 with routine balloon inflation > or = 4 atm)
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Both strategies
Number of subjects: 497
Study: 9593717

Group type: EXPERIMENTAL
Intervention: Ara h1 protein with amino acid substitutions in IgE binding epitopes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ara h1 protein
Number of subjects: 0
Study: 7988775

Group type: EXPERIMENTAL
Intervention: Polymorphisms in the insulin gene region in Caucasians
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: Polymorphisms in the insulin gene region in Tanzanian blacks
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: Polymorphisms in the insulin gene region in Japanese orientals
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: Disease-associated genotype INS +/+
Number of subjects: 840

Group type: COMPARATOR
Intervention: Contribution of particular HLA-DQ alleles
Number of subjects: 840
Study: 2925776

Group type: EXPERIMENTAL
Intervention: Ultrafiltration
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 31624941

Group type: COMPARATOR
Intervention: Same-day dose (SDD) of polyethylene glycol (PEG) starting at 7 AM on the day of colonoscopy
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Split dose (SPD) of polyethylene glycol (PEG) - 2 L at 9 PM the day before and 2 L from 10 AM on the day of colonoscopy
Number of subjects: 193

Group type: COMPARATOR
Intervention: Same-day dose (SDD)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Split dose (SPD)
Number of subjects: 193
Study: 30281073

Group type: EXPERIMENTAL
Intervention: Healthy Incentive for Pre-schools project training intervention (manager-only or manager and staff)
Number of subjects: 37
Study: 28102979

Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Present‐centered therapy
Number of subjects: 30
Study: 26457716

Group type: EXPERIMENTAL
Intervention: Very severely obese women
Number of subjects: 241

Group type: COMPARATOR
Intervention: Lean women
Number of subjects: 241
Study: 23111018

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting plus surgical ventricular reconstruction
Number of subjects: 555

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting alone
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 555
Study: 22091798

Group type: EXPERIMENTAL
Intervention: LightSheer Duet HS
Number of subjects: 36

Group type: COMPARATOR
Intervention: LightSheer ET
Number of subjects: 36
Study: 19459427

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg/day) with indapamide (1.5 mg/day)
Number of subjects: 46
Study: 17553395

Group type: EXPERIMENTAL
Intervention: Geriatric home visits (n=59)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Subacute admittance to geriatric ward (n=43)
Number of subjects: 102
Study: 14716538

Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic cholecystectomy (RLC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy (CLC)
Number of subjects: 20
Study: 11473038

Group type: EXPERIMENTAL
Intervention: gliclazide (40-80 mg twice daily for 5 weeks)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: gliclazide (acute treatment)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: gliclazide (5 weeks treatment)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: gliclazide
Number of subjects: 10
Study: 9742715

Group type: EXPERIMENTAL
Intervention: Escape option provided to participants (monkeys and humans) during memory tasks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Signal-detection analyses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimality analyses
Number of subjects: 0
Study: 8066559

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (800 micrograms beclomethasone daily)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Bronchodilators only (control group)
Number of subjects: 155
Study: 2929469

Group type: EXPERIMENTAL
Intervention: Endurance training for 4 months
Number of subjects: 26
Study: 29946644

Group type: EXPERIMENTAL
Intervention: CAD/CAM all‐ceramic inlays
Number of subjects: 97

Group type: COMPARATOR
Intervention: Ceramage polymerid porcelain inlay
Number of subjects: 97
Study: 28804807

Group type: EXPERIMENTAL
Intervention: Corticotropin-releasing hormone (CRH) injection
Number of subjects: 31

Group type: COMPARATOR
Intervention: NaCl (placebo) injection
Number of subjects: 31
Study: 25744003

Group type: EXPERIMENTAL
Intervention: Low-level transcutaneous electrical vagus nerve stimulation (LLTS) for 1 hour (20 Hz)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Low-level transcutaneous electrical vagus nerve stimulation (LLTS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 40
Study: 23682827

Group type: EXPERIMENTAL
Intervention: Single cell network profiling (SCNP) classifier
Number of subjects: 121
Study: 21283543

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard therapy without Atorvastatin
Number of subjects: 20
Study: 19255328

Group type: EXPERIMENTAL
Intervention: AZA 5-2-2 (75 mg/m(2)/d for 5 days, then 2 days no treatment, then 75 mg/m(2)/d for 2 days)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: AZA 5-2-5 (50 mg/m(2)/d for 5 days, then 2 days no treatment, then 50 mg/m(2)/d for 5 days)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: AZA 5 (75 mg/m(2)/d for 5 days)
Number of subjects: 151
Study: 16109807

Group type: EXPERIMENTAL
Intervention: Irbesartan (AT1 receptor blocker)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 15120009

Group type: EXPERIMENTAL
Intervention: Budesonide inhaled from Easyhaler (Giona Easyhaler)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Budesonide inhaled from Turbuhaler (Pulmicort Turbuhaler)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Budesonide inhaled from Turbuhaler
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Budesonide inhaled from Easyhaler
Number of subjects: 229
Study: 11227931

Group type: EXPERIMENTAL
Intervention: Electric transrectal stimulation of the pudendal nerve
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Magnetic stimulation of the sacral roots
Number of subjects: 19
Study: 8651164

Group type: EXPERIMENTAL
Intervention: Placement of a dual antimony pH electrode catheter across the LES
Number of subjects: 23

Group type: COMPARATOR
Intervention: Catheter placement 5 cm and 20 cm above the LES
Number of subjects: 23
Study: 2180405

Group type: EXPERIMENTAL
Intervention: Low-dose oral methotrexate (MTX)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Daily auranofin (AUR)
Number of subjects: 281
Study: 395523

Group type: EXPERIMENTAL
Intervention: Danazol (400 mg daily for 2 months)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 30239629

Group type: EXPERIMENTAL
Intervention: Adherence Improving Self-Management Strategy (AIMS)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 223
Study: 28158978

Group type: EXPERIMENTAL
Intervention: Mini-incision release
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Endoscopic release
Number of subjects: 67

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 67
Study: 25865966

Group type: EXPERIMENTAL
Intervention: Blond orange juice (200 mL, 3 times daily for 4 weeks)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control beverage (200 mL, 3 times daily for 4 weeks)
Number of subjects: 25
Study: 24877717

Group type: EXPERIMENTAL
Intervention: Glucevia(®) (333 mg per capsule, 3 capsules daily for 3 weeks)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Glucevia(®)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 22
Study: 22038507

Group type: EXPERIMENTAL
Intervention: Glutamine (0.5 g/kg ideal body weight/day for 2 months)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Whey protein (0.5 g/kg ideal body weight/day for 2 months)
Number of subjects: 30
Study: 20226365

Group type: EXPERIMENTAL
Intervention: Osteopathic manual therapy (OMT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional conservative therapy (CCT)
Number of subjects: 50
Study: 17903156

Group type: EXPERIMENTAL
Intervention: Red light phototherapy
Number of subjects: 28
Study: 16257842

Group type: EXPERIMENTAL
Intervention: Epoetin-alpha (aiming for hemoglobin level 135-160 g/l)
Number of subjects: 12
Study: 12153826

Group type: EXPERIMENTAL
Intervention: Risperidone (0.02-0.06 mg/kg per day)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 118
Study: 10544910

Group type: EXPERIMENTAL
Intervention: Equidivision method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hybrid method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Linear interpolation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no deletions)
Number of subjects: 0
Study: 8651966

Group type: EXPERIMENTAL
Intervention: IVIg (5 mg/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Albumin (5 mg/kg)
Number of subjects: 20
Study: 1298577

Group type: EXPERIMENTAL
Intervention: Triclosan-containing dentifrice (0.3% triclosan, 2% methoxyethylene/maleic acid copolymer, 0.243% sodium fluoride/silica base)
Number of subjects: 294

Group type: COMPARATOR
Intervention: Control dentifrice
Number of subjects: 294
Study: 6380723

Group type: EXPERIMENTAL
Intervention: Mezlocillin (2 gm intravenously 30 minutes before surgery and four and nine hours after surgery)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 113
Study: 30849615

Group type: EXPERIMENTAL
Intervention: Online engagement and empowerment intervention
Number of subjects: 182
Study: 29669026

Group type: EXPERIMENTAL
Intervention: Modified vaccinia Ankara (MVA)-vectored HIV-1 bivalent mosaic immunogen vaccine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Prototype Ad26.ENVA.01 vaccine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 28848908

Group type: EXPERIMENTAL
Intervention: Formoterol fumarate delivered by metered dose inhaler (MDI) at doses of 7.2, 9.6, and 19.2 micrograms
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Formoterol fumarate delivered by metered dose inhaler (MDI) at 9.6 micrograms
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo MDI
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Foradil(R) 12 micrograms
Number of subjects: 50
Study: 24096118

Group type: EXPERIMENTAL
Intervention: Tadalafil/finasteride
Number of subjects: 695

Group type: COMPARATOR
Intervention: Placebo/finasteride
Number of subjects: 695
Study: 22641757

Group type: EXPERIMENTAL
Intervention: 40 minutes per day of school physical education for 4 years
Number of subjects: 2395

Group type: COMPARATOR
Intervention: 60 minutes per week of physical education (control)
Number of subjects: 2395
Study: 20418299

Group type: EXPERIMENTAL
Intervention: Noninvasive positive pressure ventilation (NIPPV) immediately after tracheal extubation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Supplemental oxygen (standard group)
Number of subjects: 40
Study: 17199093

Group type: EXPERIMENTAL
Intervention: Lactobacillus casei strain Shirota (LcS) in fermented milk for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group) for 8 weeks
Number of subjects: 0
Study: 16408815

Group type: EXPERIMENTAL
Intervention: Single dose of 600 mg fudosteine
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Single dose of 400 mg fudosteine
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Single dose of 200 mg fudosteine
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Multiple dose of 400 mg fudosteine (3 times a day for 5 days)
Number of subjects: 36
Study: 11846497

Group type: EXPERIMENTAL
Intervention: Electrocardiographic parameters at presentation (Q waves, T-wave inversion, quantitative ST segment changes, initial QRS score)
Number of subjects: 146
Study: 9737803

Group type: EXPERIMENTAL
Intervention: Intramuscular soluble insulin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Subcutaneous soluble insulin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intramuscular insulin lispro
Number of subjects: 12

Group type: COMPARATOR
Intervention: Subcutaneous insulin lispro
Number of subjects: 12
Study: 8748044

Group type: EXPERIMENTAL
Intervention: Phenelzine
Number of subjects: 35

Group type: COMPARATOR
Intervention: Moclobemide
Number of subjects: 35
Study: 2221971

Group type: EXPERIMENTAL
Intervention: Donor breast milk or standard formula
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Lowest plasma prolactin concentrations (<1000 mU/l, 32.9 micrograms/l)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Protein, energy, and mineral enriched preterm formula
Number of subjects: 280
Study: 350145

Group type: EXPERIMENTAL
Intervention: Karminomycin 5 mg/m2 daily for 5 days
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Karminomycin 6 mg/m2 twice a week for 2-3 weeks
Number of subjects: 45
Study: 30471472

Group type: EXPERIMENTAL
Intervention: Postoperative care program including education sessions and explanatory leaflet on nutrition and physical exercise at home.
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group (historical control with no intervention).
Number of subjects: 124
Study: 28138944

Group type: EXPERIMENTAL
Intervention: Family Rewards program (conditional cash transfer)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 26418930

Group type: EXPERIMENTAL
Intervention: Audiovisual eyeglasses
Number of subjects: 42

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 42
Study: 24118468

Group type: EXPERIMENTAL
Intervention: Closed-loop anesthesia delivery system (CL group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Manual control (manual group)
Number of subjects: 40
Study: 21784529

Group type: EXPERIMENTAL
Intervention: BDP‐HFA 100 μg BID
Number of subjects: 63

Group type: COMPARATOR
Intervention: BDP‐CFC 200 μg BID
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: BDP‐HFA 100 μg BID and BDP‐CFC 200 μg BID
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: BDP‐HFA
Number of subjects: 63

Group type: COMPARATOR
Intervention: BDP‐CFC
Number of subjects: 63
Study: 19351812

Group type: EXPERIMENTAL
Intervention: Weekly physical therapy
Number of subjects: 29

Group type: COMPARATOR
Intervention: Monthly physical therapy
Number of subjects: 29
Study: 16879975

Group type: EXPERIMENTAL
Intervention: Cycle HRT schedule (0.625 mg conjugated estrogen from days 1 to 28 + 5 mg medroxyprogesterone acetate from days 18 to 28) for 2 months (n=25)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Continue HRT schedule (0.625 mg conjugated estrogen + 2.5 mg medroxyprogesterone acetate from days 1 to 28) for 2 months (n=25)
Number of subjects: 50
Study: 15288212

Group type: EXPERIMENTAL
Intervention: 30 microg ethinylestradiol + 2 mg dienogest (30EE/DNG)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 20 microg ethinylestradiol + 2 mg dienogest (20EE/DNG)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 10 microg ethinylestradiol + 2 mg estradiol valerate + 2 mg dienogest (EE/EV/DNG)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 20 microg ethinylestradiol + 100 microg levonorgestrel (EE/LNG)
Number of subjects: 100
Study: 11404650

Group type: EXPERIMENTAL
Intervention: Resistance exercise plus 60 min/week of jumping rope for 24 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (non-exercisers)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (non-exercisers) with OCont
Number of subjects: 0
Study: 9227252

Group type: EXPERIMENTAL
Intervention: 89Sr chloride therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: External beam radiotherapy
Number of subjects: 30
Study: 8107932

Group type: EXPERIMENTAL
Intervention: Dexfenfluramine (dF)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (non-dF)
Number of subjects: 42
Study: 2892337

Group type: EXPERIMENTAL
Intervention: Sandostatin (50 micrograms sc)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 28618052

Group type: EXPERIMENTAL
Intervention: Playing of white noise
Number of subjects: 40

Group type: COMPARATOR
Intervention: Swinging
Number of subjects: 40
Study: 27151268

Group type: EXPERIMENTAL
Intervention: MRI (n=175)
Number of subjects: 275
Study: 25044799

Group type: EXPERIMENTAL
Intervention: lorcaserin 10 mg bid
Number of subjects: 6897

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 6897
Study: 22380491

Group type: EXPERIMENTAL
Intervention: Modified Electric Vacuum Aspiration (mEVA)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Sharp Curettage (SC)
Number of subjects: 94